Intel posted Q2 2026 revenue of $16.13 billion, up 25.4% year-over-year, swinging to operating income of $1.796 billion from a $3.176 billion operating loss in Q2 2025. The Data Center & AI (DCAI) segment surged 58.9% to $6.3 billion, confirming a server CPU inventory-cycle recovery; CCPG (formerly CCG) grew 12.8%. A quarterly mark-to-market loss of $12.53 billion on Escrowed Shares derivative liability issued to the U.S. government — $13.62 billion on a first-half basis — pushed the net loss to $10.85 billion (attributable to Intel: $9.98 billion, or -$2.16 per share), wider than the year-ago loss of $3.0 billion.
1. Consolidated Balance Sheet Analysis
1-1. Key Asset Comparison
| Item | Dec 27, 2025 ($100M) | Jun 27, 2026 ($100M) | Change | Interpretation |
|---|---|---|---|---|
| Cash and cash equivalents | 142.65 | 128.74 | -9.8% | Liquidity drawn down by Apollo stake reacquisition ($14.2B) |
| Short-term investments | 231.51 | 168.53 | -27.2% | $6.3B reduction via maturities/sales; debt repayment funding |
| Accounts receivable | 38.39 | 40.33 | +5.1% | Modest growth vs. 25% revenue gain — collections intact |
| Inventories | 116.18 | 124.92 | +7.5% | WIP $8.685B; new-node ramp build |
| PP&E (net) | 1,054.14 | 1,057.41 | +0.3% | H1 D&A $5.891B offset by capex $6.192B; Fab 34 and Arizona fab capitalization ongoing |
| Goodwill | 239.12 | 204.65 | -14.4% | Mobileye reporting-unit impairment $3.447B |
| Intangible assets (net) | 27.72 | 25.45 | -8.2% | Normal amortization |
| Total assets | 2,114.29 | 2,024.39 | -4.3% | Asset reallocation, not balance-sheet erosion |
Analysis: Combined cash and short-term investments fell from $37.4 billion to $29.7 billion, a $7.7 billion (-20.6%) reduction. The primary driver was Intel's April 8 cash buyout of Apollo's 49% stake in the Ireland SCIP (Fab 34) for $14.2 billion, converting the fab to a fully-owned subsidiary. The $3.447 billion Mobileye goodwill impairment signals a downward revision in autonomous-driving expectations, with the charge allocated to non-controlling interests (-$872 million). The inventory increase reflects new-product ramp preparations rather than demand weakness.
1-2. Liability Structure — Financial vs. Operating Liabilities
Financial liabilities: Short-term borrowings $1.988 billion (prior: $2.499B) + long-term debt $48.549 billion (prior: $44.086B) = total $50.537 billion (prior: $46.585B, +8.5%). During the first half, Intel issued $13.0 billion in new bonds and repaid $9.0 billion, a net cash increase of $4.0 billion, bringing the gross debt balance from $46.585 billion to $50.537 billion (+$3.95B). Proceeds funded capital expenditure and the Apollo stake purchase.
Operating liabilities: Accounts payable $8.756 billion (-11.4%), accrued compensation $3.748 billion (-6.1%), other accrued liabilities $21.178 billion (+39.3%), other long-term liabilities $15.077 billion (+60.3%). The surge in other liabilities reflects the Escrowed Shares derivative liability issued to the government — $8.8 billion current + $6.8 billion long-term = $15.6 billion (prior: $3.95B). This is an accounting liability, not a cash-settlement obligation; it is an equity-settled derivative.
1-3. Equity Structure
Paid-in capital dropped from $65.185 billion to $53.780 billion, a $11.4 billion decline, as $13.545 billion of the $14.2 billion Apollo payment was treated as a "reduction from equity (residual consideration)." Retained earnings fell from $48.983 billion to $33.842 billion, down $15.14 billion (-30.9%), directly absorbing the $15.129 billion H1 net loss. Intel shareholders' equity eroded from $114.281 billion to $87.542 billion, a $26.7 billion (-23.4%) reduction. Non-controlling interests rose from $12.079 billion to $15.601 billion, boosted by Brookfield's additional $4.082 billion investment in the Arizona SCIP.
2. Consolidated Income Statement Analysis
2-1. Key Profit Metrics (Three Months)
| Item | Q2 2025 ($100M) | Q2 2026 ($100M) | Change |
|---|---|---|---|
| Revenue | 128.59 | 161.28 | +25.4% |
| Gross profit | 35.42 | 65.09 | +83.8% |
| Gross margin (%) | 27.5% | 40.4% | +12.8pp |
| Operating income (loss) | -31.76 | 17.96 | Turned positive |
| Operating margin (%) | -24.7% | 11.1% | +35.8pp |
| Net income (loss) | -30.24 | -108.48 | Loss widened |
| Net margin (%) | -23.5% | -67.3% | — |
Analysis: The 12.8 percentage-point gross-margin expansion — from 27.5% to 40.4% — is the quarter's most consequential metric. Cost of sales fell from 72.5% to 59.6% of revenue, driven by the absence of year-ago one-time charges (including a $460 million fab asset impairment) and improved yields on newer nodes. DCAI segment operating income jumped from $633 million to $2.474 billion, +290.8%, the fulcrum of the earnings reversal, signaling resumed hyperscaler ordering and a server CPU replacement cycle. Intel Foundry remained loss-making despite 30.5% revenue growth, with an operating loss of -$2.089 billion — still short of breakeven scale.
Net loss widened solely on non-operating items. "Interest and other" totaled -$12.576 billion, of which $12.529 billion was the mark-to-market loss on the Escrowed Shares derivative liability. (Warrants for 241 million shares at a $20 strike price, exercisable if foundry ownership falls below 51%, were excluded from EPS given remote probability of exercise.) This is a pure accounting charge with no cash impact.
2-2. Fixed vs. Variable Cost Structure
Fixed-cost items: R&D $3.368 billion (-8.6% YoY, modestly trimmed by restructuring), SG&A $1.175 billion (+2.7%), stock-based compensation $687 million (+3.5%), D&A (H1) $5.891 billion (+13.0%). The D&A increase reflects the ongoing capitalization of Arizona and Ireland fab assets; even with 25% revenue growth, this fixed-cost drag continues to expand.
Variable-cost items: Cost of sales $9.619 billion (+3.2%) against 25% revenue growth. Operating leverage functioned precisely this quarter — rising fab utilization compressed unit costs. However, Intel Foundry's cost structure still exceeds 100% of its revenue (Q2 revenue $5.765B vs. costs and expenses $7.854B); foundry breakeven remains distant.
3. Cash Flow Statement Analysis (Six Months)
| Item | H1 2025 ($100M) | H1 2026 ($100M) | Change |
|---|---|---|---|
| Operating cash flow | 28.63 | 81.02 | +52.39 |
| Investing cash flow | -20.05 | -6.69 | +13.36 |
| Financing cash flow | 5.86 | -85.48 | -91.34 |
| Ending cash (incl. restricted) | 96.93 | 135.97 | +39.04 |
Analysis: Operating cash flow surging from $2.863 billion to $8.102 billion (+183%) is the strongest evidence of fundamental improvement. Despite a net loss of -$15.129 billion, non-cash add-backs — D&A $5.891 billion, restructuring charges $3.967 billion, Escrowed Shares mark-to-market $13.619 billion — restored operating cash generation. Net income taxes paid fell to $904 million from $1.793 billion, reflecting a $678 million CHIPS Act tax credit.
Capex: Property, plant and equipment additions of $6.192 billion (-29.1% vs. $8.733B in H1 2025). Net of government incentives received ($167 million), net capex was approximately $6.0 billion. Free cash flow (FCF) = $8.102B − $6.192B = $1.910 billion, a sharp reversal from -$5.87 billion in H1 2025.
Financing: Partner distributions related to the Apollo stake reacquisition (-$14.339 billion) dominate outflows; this is a one-time item partially offset by Brookfield's capital injection of $4.082 billion. Bond issuances of $13.0 billion against $9.0 billion in repayments (net cash +$4.0 billion) lifted gross debt from $46.585 billion to $50.537 billion, providing a liquidity buffer.
4. Key Additional Analysis
The U.S. government equity stake — the mechanics: Under the August 22, 2025 agreement with the Department of Commerce (U.S. Government Agreement), Intel issued warrants and Escrowed Shares in exchange for CHIPS Act grants. Over the first half, 13 million shares were released; of the remaining 143 million unreleased shares, 71 million are already reflected in diluted EPS. 241 million warrants at a $20 strike (exercisable if foundry ownership falls below 51%) remain outstanding — a financial backstop and a potential dilution overhang simultaneously.
Intel Foundry loss trajectory: H1 cumulative operating loss -$4.526 billion (vs. -$5.488 billion in H1 2025). External customer revenue reached $467 million in H1 (vs. $53 million prior year), an 8.8× increase, but still far from standalone breakeven. The ramp and reception of the Intel 14A node over the next 12–18 months is the single largest valuation determinant.
Mobileye $3.447 billion goodwill impairment: Intel acknowledged a prolonged autonomous-driving recovery delay. The non-controlling interest percentage in Mobileye rose from 13% to 23% year-over-year (Intel's stake diluted from 87% to 77%), signaling ongoing ownership restructuring.
Ireland SCIP 100% reacquisition: Full control of Fab 34 with 100% future profit capture — at the cost of $14.2 billion in cash and elimination of the $532 million contingent consideration derivative liability.
Arizona SCIP new fab commercial production commencement: Production contracts became effective in Q1 2026. Volume-shortfall penalties apply if minimum production levels or inventory limits are breached — a contractually defined downside risk.
5. Key Takeaways and Outlook
Bull case: The 40% gross margin recovery and ~3.9× DCAI operating income expansion signal a cycle trough has passed. A $7.78 billion FCF swing in six months (from -$5.87B to $1.91B) restores self-funding capacity; U.S. government strategic capital participation effectively eliminates near-term financing risk. On-schedule Intel 18A/14A node ramps could make foundry economics visible by 2027.
Risks: ①The $15.6 billion Escrowed Shares derivative liability will generate large accounting losses whenever Intel's stock price rises — a paradox in which improving share performance worsens reported EPS. ②241 million warrants represent potential dilution. ③Intel Foundry continues to bleed: -$4.526 billion in H1 2026 (-$5.488 billion H1 2025); failure to land large external customers reopens impairment risk. ④Retained earnings down 30%, ruling out near-term dividend reinstatement. ⑤China/Taiwan geopolitical exposure and evolving tariff and export-control policy.
Summary: Business fundamentals are clearly in recovery, but government-linked equity accounting will distort reported EPS for several quarters. Investors should anchor to gross margin, segment operating income, and FCF — not the GAAP net-loss headline.
Disclaimer
This report is prepared for informational purposes based on the 10-Q (quarterly report) filed with the SEC and does not constitute investment advice.